Anthony Fauci, MD, addresses potential vaccine mandates once COVID-19 vaccines gain full approval; the FDA issues finalized guidance on using a metastasis-free survival end point in clinical trials of patients with prostate cancer; spotlighting the threat of variant spread and mutation amid case surges nationwide.
As reported by USA Today, the nation’s top infectious disease expert and chief medical advisor to President Joe Biden, Anthony Fauci, MD, said this past Friday there will be “a flood” of vaccine mandates at businesses and schools nationwide once the FDA issues a full approval for a COVID-19 vaccine. Although mandates will likely not occur at a federal level, Fauci said that the approval would encourage organizations, universities, and hospitals to require proof of vaccination for workers and students. Currently, each FDA-approved COVID-19 vaccine is under emergency use authorization status, which Fauci hopes will be expanded to full approval in the next few weeks.
The FDA has issued finalized guidance on the use of metastasis-free survival (MFS) as an end point in clinical trials for patients with nonmetastatic castration-resistant prostate cancer. Reported by Regulatory Focus, the final guidance provides recommendations for sponsors on general trial design, imaging, and interpretation of trial results and analyses of MFS, which could prove useful in determining the efficacy of potential drugs earlier in the disease course. Coming 3 years after the FDA initially released a draft version on the guidance for MFS, some therapies have already been approved on the basis of MFS as a primary end point.
With surges in COVID-19 infections and hospitalizations in states such as Texas and Florida mirroring or even surpassing rates seen at the onset of pandemic, an article by CNN Health highlights the threat of variant spread and mutation among unvaccinated individuals across the nation. According to Johns Hopkins University, the United States is averaging its highest rate of daily COVID-19 cases in nearly 6 months, with a 10% increase in 7-day case averages observed among 47 states in the past week. Vaccines have been shown to provide effective protection against severe disease for those infected with the more transmissible delta variant, but concerns have been noted on whether vaccinated individuals can still spread the virus.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More